Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Dealing with renin-angiotensin inhibitors, don't mind serum creatinine.

× No keyword cloud information.

8 in total

1. Consequences of Overinterpreting Serum Creatinine Increases when Achieving BP Reduction: Balancing Risks and Benefits of BP Reduction in Hypertension.

Authors: Hala Yamout; George L Bakris
Journal: Clin J Am Soc Nephrol Date: 2017-11-03 Impact factor: 8.237

2. Comparison of long-term safety of fixed-dose combinations azilsartan medoxomil/chlorthalidone vs olmesartan medoxomil/hydrochlorothiazide.

Authors: Joel M Neutel; William C Cushman; Eric Lloyd; Bruce Barger; Alison Handley
Journal: J Clin Hypertens (Greenwich) Date: 2017-07-06 Impact factor: 3.738

3. Acute Declines in Renal Function during Intensive BP Lowering: Implications for Future ESRD Risk.

Authors: Elaine Ku; George Bakris; Kirsten L Johansen; Feng Lin; Mark J Sarnak; Vito M Campese; Kenneth Jamerson; Jennifer J Gassman; Miroslaw Smogorzewski; Chi-Yuan Hsu
Journal: J Am Soc Nephrol Date: 2017-05-04 Impact factor: 14.978

4. Rates and predictors of ACE inhibitor discontinuation subsequent to elevated serum creatinine: a retrospective cohort study.

Authors: Cynthia A Jackevicius; Joyce Wong; Irina Aroustamian; Manyee Gee; Freny Vaghaiwalla Mody
Journal: BMJ Open Date: 2014 Impact factor: 2.692

5. Safety, tolerability, and efficacy of azilsartan medoxomil with or without chlorthalidone during and after 8 months of treatment for hypertension.

Authors: Mark S Kipnes; Alison Handley; Eric Lloyd; Bruce Barger; Andrew Roberts
Journal: J Clin Hypertens (Greenwich) Date: 2015-01-24 Impact factor: 3.738

6. The roles of sodium and volume overload on hypertension in chronic kidney disease.

Authors: Jinho Shin; Chang Hwa Lee
Journal: Kidney Res Clin Pract Date: 2021-11-17

7. Cardiovascular Outcomes According to Systolic Blood Pressure in Patients With and Without Diabetes: An ACCOMPLISH Substudy.

Authors: Michael A Weber; Michael Bloch; George L Bakris; Matthew R Weir; Dion H Zappe; Bjorn Dahlof; Eric J Velazquez; Bertram Pitt; Jan N Basile; Kenneth Jamerson; Tsushung A Hua
Journal: J Clin Hypertens (Greenwich) Date: 2016-03-28 Impact factor: 3.738

8. Safety and tolerability of azilsartan medoxomil in subjects with essential hypertension: a one-year, phase 3, open-label study.

Authors: Alison Handley; Eric Lloyd; Andrew Roberts; Bruce Barger
Journal: Clin Exp Hypertens Date: 2016-01-28 Impact factor: 1.749

8 in total